Table of TCGA Cancer Codes TCGA code
Cancer type Number*
ACC Adrenocortical carcinoma 90 BLCA Bladder urothelial carcinoma 396 BRCA Breast invasive carcinoma 988 CESC Cervical squamous cell carcinoma and endocervical
adenocarcinoma 194
CHOL Cholangiocarcinoma (bile duct) 35 COAD Colon adenocarcinoma 367 DLBC Lymphoid neoplasm diffuse large B−cell lymphoma 48 ESCA Esophageal carcinoma 185 GBM Glioblastoma multiforme 290 HNSC Head and neck squamous cell carcinoma 513 KICH Kidney chromophobe 66 KIRC Kidney renal clear cell carcinoma 451 KIRP Kidney renal papillary cell carcinoma 282 LAML Acute myeloid leukemia 197 LGG Brain lower grade glioma 533 LIHC Liver hepatocellular carcinoma 373 LUAD Lung adenocarcinoma 546 LUSC Lung squamous cell carcinoma 178 OV Ovarian serous cystadenocarcinoma 469 PAAD Pancreatic adenocarcinoma 185 PCPG Pheochromocytoma and paraganglioma (adrenal gland) 184 PRAD Prostate adenocarcinoma 499 READ Rectum adenocarcinoma 122 SARC Sarcoma 247 SKCM Skin cutaneous melanoma 371 STAD Stomach adenocarcinoma 395 TGCT Testicular germ cell tumors 155 THCA Thyroid carcinoma 504 THYM Thymoma 123 UCEC Uterine corpus endometrial carcinoma 248 UCS Uterine carcinosarcoma 57 UVM Uveal melanoma 8 *Number of samples with mutation data
G13
D
Q61
H
G12
R
L19F
G12
C
G12
V
G12
D
KRAS mutant alleles in bladder urothelial carcinoma (N=396)0
12
34
5
NbrSamples=396 Mutant Samples=13 Total Mutations=13
G13
Q61 L1
9
G12
KRAS mutant positions in bladder urothelial carcinoma (N=396)0
24
68
10
NbrSamples=396 Mutant Samples=13 Total Mutations=13
D92
Y
G12
C
G12
D
G12
V
KRAS mutant alleles in breast invasive carcinoma (N=988)0.
00.
51.
01.
52.
02.
53.
0
NbrSamples=988 Mutant Samples=6 Total Mutations=6
D92
G12
KRAS mutant positions in breast invasive carcinoma (N=988)0
12
34
5
NbrSamples=988 Mutant Samples=6 Total Mutations=6
A14
6T
G12
C
I21R
G13
D
G12
V
G12
D
KRAS mutant alleles in cervical squamous cell carcinoma and endocervical adenocarcinoma (N=194)
01
23
4
NbrSamples=194 Mutant Samples=11 Total Mutations=11
A14
6
I21
G13
G12
KRAS mutant positions in cervical squamous cell carcinoma and endocervical adenocarcinoma (N=194)
01
23
45
67
NbrSamples=194 Mutant Samples=11 Total Mutations=11
A14
6VR
68G
A14
6GL1
9FV
8AV
14G
Y71
CQ
61P
I24V
K11
7EQ
61H
D69
GK
5RS
17G
M72
VG
12R
Q61
KK
117N
G12
SG
12A
G12
CA
146T
G13
DG
12V
G12
D
KRAS mutant alleles in colon adenocarcinoma (N=367), top 250
1020
3040
NbrSamples=367 Mutant Samples=168 Total Mutations=182(21 not shown)
C80
D92
T20
E63
G10 V
9H
27E
62P
34 L19
V8
Y71 I2
4D
69 K5
R68
S17
Q22
M72
V14
K11
7Q
61A
146
G13
G12
KRAS mutant positions in colon adenocarcinoma (N=367), top 250
2040
6080
NbrSamples=367 Mutant Samples=168 Total Mutations=182 (2 not shown)
G12
V
G12
D
KRAS mutant alleles in kidney renal papillary cell carcinoma (N=282)0.
00.
51.
01.
52.
02.
53.
0
NbrSamples=282 Mutant Samples=5 Total Mutations=5
G12
KRAS mutant positions in kidney renal papillary cell carcinoma (N=282)0
12
34
5
NbrSamples=282 Mutant Samples=5 Total Mutations=5
Q61
H
G12
V
A59
E
I36M
A14
6T
G13
D
G12
D
KRAS mutant alleles in acute myeloid leukemia (N=197)0.
00.
51.
01.
52.
0
NbrSamples=197 Mutant Samples=8 Total Mutations=8
Q61
A59 I3
6
A14
6
G13
G12
KRAS mutant positions in acute myeloid leukemia (N=197)0.
00.
51.
01.
52.
02.
53.
0
NbrSamples=197 Mutant Samples=8 Total Mutations=8
G12
C
R16
1G
G13
D
R68
M
G12
D
KRAS mutant alleles in liver hepatocellular carcinoma (N=373)0.
00.
51.
01.
52.
0
NbrSamples=373 Mutant Samples=6 Total Mutations=6
R16
1
G13
R68
G12
KRAS mutant positions in liver hepatocellular carcinoma (N=373)0.
00.
51.
01.
52.
02.
53.
0
NbrSamples=373 Mutant Samples=6 Total Mutations=6
K88
*
Q61
H
A14
6P
D33
E
G12
R
Q61
E
G13
D
Q61
L
L19F
G12
S
G13
C
G12
A
G12
D
G12
V
G12
C
KRAS mutant alleles in lung adenocarcinoma (N=546)0
1020
3040
5060
NbrSamples=546 Mutant Samples=164 Total Mutations=169
K88
A14
6
D33 L1
9
Q61
G13
G12
KRAS mutant positions in lung adenocarcinoma (N=546)0
2040
6080
100
120
140
NbrSamples=546 Mutant Samples=164 Total Mutations=169
G12
R
G12
V
KRAS mutant alleles in ovarian serous cystadenocarcinoma (N=469)0
12
34
NbrSamples=469 Mutant Samples=5 Total Mutations=5
G12
KRAS mutant positions in ovarian serous cystadenocarcinoma (N=469)0
12
34
5
NbrSamples=469 Mutant Samples=5 Total Mutations=5
G12
S
G12
C
Q61
R
Q61
H
G12
R
G12
V
G12
D
KRAS mutant alleles in pancreatic adenocarcinoma (N=185)0
1020
3040
5060
NbrSamples=185 Mutant Samples=140 Total Mutations=143
Q61
G12
KRAS mutant positions in pancreatic adenocarcinoma (N=185)0
2040
6080
100
120
NbrSamples=185 Mutant Samples=140 Total Mutations=143
A14
6V
Q61
H
K11
7N
E98
*
G12
F
Q22
K
Q61
L
12_1
2G>
GA
G
A59
T
M72
T
V9I
G12
A
G12
S
G12
C
A14
6T
G13
D
G12
D
G12
V
KRAS mutant alleles in rectum adenocarcinoma (N=122)0
24
68
1012
14
NbrSamples=122 Mutant Samples=63 Total Mutations=63
K11
7
E98
Q22
12_1
2G>
GA
G
A59
M72 V
9
Q61
A14
6
G13
G12
KRAS mutant positions in rectum adenocarcinoma (N=122)0
510
1520
2530
35
NbrSamples=122 Mutant Samples=63 Total Mutations=63
G12
R
Q61
K
Q61
R
E62
K
K11
7N
G13
D
G12
D
KRAS mutant alleles in skin cutaneous melanoma (N=371)0.
00.
51.
01.
52.
0
NbrSamples=371 Mutant Samples=7 Total Mutations=8
E62
K11
7
G13
Q61
G12
KRAS mutant positions in skin cutaneous melanoma (N=371)0.
00.
51.
01.
52.
02.
53.
0
NbrSamples=371 Mutant Samples=7 Total Mutations=8
R13
5T
G12
C
Q61
H
A14
6T
G12
V
G12
S
G12
D
G13
D
KRAS mutant alleles in stomach adenocarcinoma (N=395)0
24
68
1012
NbrSamples=395 Mutant Samples=37 Total Mutations=37
R13
5
Q61
A14
6
G13
G12
KRAS mutant positions in stomach adenocarcinoma (N=395)0
510
15
NbrSamples=395 Mutant Samples=37 Total Mutations=37
E63
K
G12
S
A14
6P
A14
6V
Q61
L
G12
A
Q61
H
G12
R
A14
6T
G12
V
Q61
R
KRAS mutant alleles in testicular germ cell tumors (N=155)0.
00.
51.
01.
52.
02.
53.
0
NbrSamples=155 Mutant Samples=20 Total Mutations=20
E63
A14
6
Q61
G12
KRAS mutant positions in testicular germ cell tumors (N=155)0
24
68
NbrSamples=155 Mutant Samples=20 Total Mutations=20
Q61
R
G12
V
Q61
K
KRAS mutant alleles in thyroid carcinoma (N=504)0.
00.
51.
01.
52.
0
NbrSamples=504 Mutant Samples=5 Total Mutations=5
G12
Q61
KRAS mutant positions in thyroid carcinoma (N=504)0.
00.
51.
01.
52.
02.
53.
0
NbrSamples=504 Mutant Samples=5 Total Mutations=5
P11
0S
K17
6Q
Q61
L
G12
S
T20
R
G13
C
G13
V
R16
4Q
Q61
H
G12
C
G12
A
G13
D
G12
V
G12
D
KRAS mutant alleles in uterine corpus endometrial carcinoma (N=248)0
510
15
NbrSamples=248 Mutant Samples=52 Total Mutations=52
P11
0
K17
6
T20
R16
4
Q61
G13
G12
KRAS mutant positions in uterine corpus endometrial carcinoma (N=248)0
510
1520
2530
35
NbrSamples=248 Mutant Samples=52 Total Mutations=52
G12
C
G12
A
G12
D
G12
V
KRAS mutant alleles in uterine carcinosarcoma (N=248)0.
00.
51.
01.
52.
02.
53.
0
NbrSamples=57 Mutant Samples=7 Total Mutations=7
G12
KRAS mutant positions in uterine carcinosarcoma (N=248)0
12
34
56
7
NbrSamples=57 Mutant Samples=7 Total Mutations=7
V14
I
V8A
V9F V9I
Y71
C
A14
6P
E63
K
M72
T
A14
6V
K11
7N
Q22
K
G13
C
L19F
Q61
K
Q61
L
Q61
R
A14
6T
G12
A
G12
S
G12
R
G13
D
G12
C
Q61
H
G12
V
G12
D
Number of cancer types where each KRAS mutation occurs, top 250
510
15
48 not shown
R13
5
R16
1
R16
4
T15
8
T35
V14 V8
Y71
D92
E62
E63 K5
M72
R68
S17
T20 V
9
A59
K11
7
Q22 L1
9
A14
6
G13
Q61
G12
Number of cancer types where each KRAS mutation position occurs, top 250
510
1520
16 not shown
R16
4Q
D69
G
K5R
E63
K
M72
T
S17
G
M72
V
A14
6P
Q22
K
A14
6V
L19F
K11
7N
Q61
K
Q61
R
Q61
L
G13
C
G12
S
Q61
H
A14
6T
G12
A
G12
R
G13
D
G12
C
G12
V
G12
D
Number of times each KRAS mutation occurs across all cancer types, top 250
5010
015
0
48 not shown
E98
12_1
2G>
GA
G
R13
5
P11
0
K17
6
R16
4
D92
D69
T20
E63 V9
E62 K5
R68
S17
V14
A59
M72
Q22 L1
9
K11
7
A14
6
Q61
G13
G12
Number of times each KRAS mutation position occurs across all cancer types, top 250
100
200
300
400
500
16 not shown
CH
OL
DLB
CLG
GT
HY
ME
SC
AG
BM
PR
AD
TH
CA
LAM
LLI
HC
SK
CM
BR
CA
KIR
PO
VC
ES
CU
CS
TG
CT
BLC
AS
TAD
UC
EC
RE
AD
CO
AD
PAA
DLU
AD
Total number of KRAS G12 mutations in different cancer types0
2040
6080
100
120
140
CH
OL
DLB
CLG
GT
HY
ME
SC
AG
BM
PR
AD
TH
CA
LAM
LLI
HC
SK
CM
BR
CA
KIR
PO
VC
ES
CU
CS
TG
CT
BLC
AS
TAD
UC
EC
RE
AD
CO
AD
PAA
DLU
AD
Mutated allele breakdown for KRAS G12 mutations0
2040
6080
100
120
140 G12D
G12CG12VG12RG12SG12AG12F
CH
OL
DLB
CLG
GT
HY
ME
SC
AG
BM
PR
AD
TH
CA
LAM
LLI
HC
SK
CM
BR
CA
KIR
PO
VC
ES
CU
CS
TG
CT
BLC
AS
TAD
UC
EC
RE
AD
CO
AD
PAA
DLU
AD All
0.0
0.2
0.4
0.6
0.8
1.0
Proportional View of Allele Breakdown of KRAS G12 Mutations 1 1 1 1 2 2 2 2 3 3 3 5 5 5 7 7 8 10 19 36 38 96 135149541
G12DG12CG12VG12RG12SG12AG12F
BLC
A
LAM
L
LIH
C
SA
RC
SK
CM
CE
SC
LUA
D
UC
EC
RE
AD
STA
D
CO
AD
Total number of KRAS G13 mutations in different cancer types0
510
1520
25
BLC
A
LAM
L
LIH
C
SA
RC
SK
CM
CE
SC
LUA
D
UC
EC
RE
AD
STA
D
CO
AD
Mutated allele breakdown for KRAS G13 mutations0
510
1520
25 G13DG13SG13CG13V
BLC
A
LAM
L
LIH
C
SA
RC
SK
CM
CE
SC
LUA
D
UC
EC
RE
AD
STA
D
CO
AD All
Proportional view of allele breakdown of KRAS G13 mutations0.
00.
20.
40.
60.
81.
0 1 1 1 1 1 2 9 9 11 12 26 74
G13DG13SG13CG13V
BLC
A
CH
OL
ES
CA
LAM
L
LUS
C
SA
RC
RE
AD
SK
CM
STA
D
TH
CA
UC
EC
LUA
D
TG
CT
PAA
D
CO
AD
Total number of KRAS Q61 mutations in different cancer types0
24
68
BLC
A
CH
OL
ES
CA
LAM
L
LUS
C
SA
RC
RE
AD
SK
CM
STA
D
TH
CA
UC
EC
LUA
D
TG
CT
PAA
D
CO
AD
Mutated allele breakdown for KRAS Q61 mutations0
24
68
Q61HQ61KQ61RQ61LQ61PQ61E
BLC
A
CH
OL
ES
CA
LAM
L
LUS
C
SA
RC
RE
AD
SK
CM
STA
D
TH
CA
UC
EC
LUA
D
TG
CT
PAA
D
CO
AD All
Proportional view of allele breakdown of KRAS Q61 mutations0.
00.
20.
40.
60.
81.
0 1 1 1 1 1 1 2 2 2 3 3 5 7 8 9 47
Q61HQ61KQ61RQ61LQ61PQ61E
CE
SC
LAM
L
LUA
D
STA
D
TG
CT
RE
AD
CO
AD
Total number of KRAS A146 mutations in different cancer types0
24
68
1012
14
CE
SC
LAM
L
LUA
D
STA
D
TG
CT
RE
AD
CO
AD
Mutated allele breakdown for KRAS A146 mutations0
24
68
1012
14
A146TA146VA146GA146P
CE
SC
LAM
L
LUA
D
STA
D
TG
CT
RE
AD
CO
AD All
Proportional view of allele breakdown of KRAS A146 mutations0.
00.
20.
40.
60.
81.
0 1 1 1 3 4 5 15 30
A146TA146VA146GA146P
RE
AD
SK
CM
CO
AD
Total number of KRAS K117 mutations in different cancer types0
12
34
5
RE
AD
SK
CM
CO
AD
Mutated allele breakdown for KRAS K117 mutations0
12
34
5
K117NK117E
RE
AD
SK
CM
CO
AD All
Proportional view of allele breakdown of KRAS K117 mutations0.
00.
20.
40.
60.
81.
0 1 1 5 7
K117NK117E
DLB
CLG
GLU
SC
TH
YM
CH
OL
GB
MP
RA
DS
AR
CE
SC
ALI
HC
BR
CA
KIR
PO
VT
HC
ALA
ML
SK
CM
UC
SC
ES
CB
LCA
TG
CT
STA
DU
CE
CR
EA
DPA
AD
CO
AD
LUA
D
Positional breakdown of KRAS mutations across cancer types0
5010
015
0 G12G13Q61A146K117
DLB
CLG
GLU
SC
TH
YM
CH
OL
GB
MP
RA
DS
AR
CE
SC
ALI
HC
BR
CA
KIR
PO
VT
HC
ALA
ML
SK
CM
UC
SC
ES
CB
LCA
TG
CT
STA
DU
CE
CR
EA
DPA
AD
CO
AD
LUA
D All
Proportional Position Breakdown of KRAS Mutations0.
00.
20.
40.
60.
81.
0 1 1 1 1 2 2 2 2 3 4 5 5 5 5 6 7 7 10 12 19 36 48 57 143
151
164
699
G12G13Q61A146K117
![· Web viewIn the Cancer Genome Atlas (TCGA) project, the somatic cancer variants were annotated in four different layers, including tumor types, genes, variants, and drugs [23]](https://static.documents.pub/doc/80x56/5ea7ba4a9e40290ae43e482f/web-view-in-the-cancer-genome-atlas-tcga-project-the-somatic-cancer-variants.jpg)
